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ABSTRACT
Vernal keratoconjunctivitis (VKC), a severe form of ocular allergic disease, is characterized by the formation of
giant papillae at the upper tarsal conjunctiva and corneal lesions that threaten vision. Recent evidence indi-
cates that resident fibroblasts function as immune modulators in the pathogenesis of the chronic allergic inflam-
mation associated with VKC. The T helper 2 (Th2) cell-derived cytokines interleukin (IL)-4 and IL-13 stimulate
the migration and proliferation of conjunctival fibroblasts as well as protecting these cells from apoptotic cell
death, effects that likely underlie the hyperplasia of fibroblasts that contributes to the formation of giant papillae.
Conjunctival fibroblasts also synthesize extracellular matrix proteins and tissue inhibitors of metalloproteinases
as well as down-regulate the expression of matrix metalloproteinases in response to these cytokines, effects
that likely contribute to the excessive deposition of extracellular matrix that is characteristic of giant papillae.
Stimulation of fibroblasts in the corneal stroma with the combination of a proinflammatory cytokine and either
IL-4 or IL-13 results in up-regulation of the expression of the chemokine eotaxin and thymus- and activation-
regulated chemokine as well as of vascular cell adhesion molecule-1, which together mediate the infiltration
and activation of eosinophils and Th2 cells. Fibroblasts therefore appear to play a central role in the induction
and amplification of ocular allergic inflammation and the consequent development of giant papillae and corneal
disorders in individuals with VKC. Fibroblasts and fibroblast-derived factors thus represent new and potentially
important therapeutic targets for treatment of the giant papillae and corneal disorders associated with VKC.
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INTRODUCTION
Ocular allergic diseases are triggered by the invasion
of antigens, such as grass or tree pollen, dead mites,
and skin debris of various animals, into the conjunc-
tiva of sensitized individuals. Both the tarsal and bul-
bar conjunctiva possess an extensive vasculature and
are rich in immune cells such as mast cells, eosino-
phils, macrophages, and lymphocytes, characteristics
that confer high susceptibility to allergic reactions
(Fig. 1A). Allergic conjunctival diseases are classified
into several subtypes−including allergic conjunctivi-
tis, atopic keratoconjunctivitis, vernal keratoconjunc-
tivitis (VKC),and giant papillary conjunctivitis−on the
basis of the absence or presence of conjunctival pro-
liferative changes, atopic dermatitis, and conjunctival
foreign bodies. Individuals with allergic conjunctivitis
experience ocular itching, tearing, or a watery dis-
charge as a result of acute conjunctival inflammation,
but they usually manifest only mild hyperemia or
edema of the conjunctiva. The cornea is not involved
in allergic conjunctivitis, with the result that vision is
not disturbed.
In contrast to the acute nature of allergic conjuncti-
vitis, VKC is a chronic and severe ocular allergic dis-
ease.1 VKC is characterized by pronounced and per-
sistent allergic inflammation of the conjunctiva that is
accompanied by ocular itching , pain , mucous dis-
charge, and visual disturbance. Conjunctival prolifera-
tive lesions, such as giant papillae of the upper tarsal
conjunctiva (Fig. 1B), and swollen limbal lesions are
characteristic of VKC; they are not associated with
other types of ocular inflammatory disease with the
exception of giant papillary conjunctivitis.
The cornea and conjunctiva are separated from
each other by only a thin layer of tear fluid(Fig. 1A).
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Fig. 1 Anatomy of the ocular surface and clinical characteristics of VKC. (A) The cornea and conjunctiva are separated 
by a thin layer of tear fluid. (B) Giant papila of the tarsal conjunctiva in an individual with VKC. (C) Corneal shield ulcer 
in an individual with VKC. 
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The cornea has a unique structure because of its role
in vision . It is a transparent and avascular tissue ,
lacks immune cells (with the exception of Langer-
hans’ cells at the periphery of the corneal epithe-
lium), and is composed of only three types of struc-
tural cells (epithelial cells , stromal fibroblasts , and
corneal endothelial cells), with corneal epithelial cells
forming a tight barrier between the tissue and the ex-
ternal environment (Fig. 1A) . These characteristics
render the cornea resistant to primary allergic reac-
tions. However, the cornea is influenced by allergic
inflammation of the conjunctiva as a result of the re-
lease of bioactive substances such as histamine, en-
zymes , cytokines , and eosinophil-derived cytotoxic
proteins into tear fluid as well as through direct con-
tact and neuronal communication . 2-6 Indeed , more
than 50% of individuals with VKC have corneal lesions
(Fig. 1C) that result in disturbance of vision.7 The
symptoms of most patients with allergic conjunctivitis
can be controlled by topical administration of antial-
lergy eyedrops such as those containing mast cell sta-
bilizers or antihistamines, given the predominant role
of the early-phase reaction induced by degranulation
of mast cells in this disease. However, corneal lesions
and conjunctival proliferative changes in individuals
with VKC are often resistant to such therapy and re-
main a challenge in the treatment of ocular allergy.7
Recent studies have revealed that interaction of im-
mune cell-mediated inflammatory processes with a
network of nonimmune cell types contributes to the
development of VKC, with the effector activities of
these latter cells being responsible for the giant papil-
lae and corneal disorders associated with this condi-
tion.8,9 Thus, although until recently, the nonimmune
cell constituents of tissues, such as epithelial cells
and fibroblasts, were regarded as mere targets of the
inflammatory milieu and as secondary players in the
development of allergic disease, new data implicate
such cells as dominant players in the pathogenesis of
VKC. This review focuses on our current knowledge
of the biology of ocular resident fibroblasts and their
role in the development of VKC.
CYTOKINES AND GROWTH FACTORS IN
OCULAR ALLERGIC DISEASES
The concentrations of various inflammatory media-
tors, including growth factors and cytokines released
from inflammatory cells, are increased in the conjunc-
tiva and tear fluid of patients with VKC. The levels of
transforming growth factor-β, platelet-derived growth
factor, and fibroblast growth factor, for example, are
increased in the giant papillae of such individuals.10
Inflammatory cells associated with giant papillae in-
clude mast cells, eosinophils, and T helper (Th) cells.
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Fig. 2 Interaction between conjunctival resident fibro-
blasts and infiltrated eosinophils in giant papilae. Electron 
microscopy reveals the interaction of a fibroblast (Fb) with 
an eosinophil (Eo) and the accumulation of colagen fibers 
in a giant papila of an individual with VKC. Scale bar, 2 μm.
Fb
Eo
Immunohistochemical analysis and in vitro cloning of
T cells have revealed that infiltrated Th cells in the
conjunctiva of VKC patients comprise mostly Th2
cells.11 Whereas VKC results from Th2-dominant in-
flammation, most other types of conjunctivitis, includ-
ing those associated with infection or autoimmune
disease, result from Th1-dominant inflammation. It
was thus thought possible that the activation of con-
junctival fibroblasts during Th2-dominant inflamma-
tion contributes to the formation of the giant papillae
that are largely specific to VKC. However, it has been
unclear whether Th2 cell-derived cytokines such as
interleukin (IL) -4 and IL-13 affect the functions of
tissue-resident fibroblasts.
Until recently, Th2 cytokines were thought to act
only on immune cells such as T cells and B cells .
However, we and others have shown that not only im-
mune cells but also the nonimmune cellular constitu-
ents of tissue, such as fibroblasts and epithelial cells,
express receptors for these cytokines.12,13 We have
thus characterized the IL-4 receptor (IL-4R) complex
expressed on the surface of human corneal and con-
junctival fibroblasts,13-15 showing that it consists of IL-
4Rα, IL-2Rγc, IL-13Rα1, and IL-13Rα2 chains. Binding
assays revealed that IL-4 binds with high affinity (dis-
sociation constant,10 pM) to these receptors. Fur-
thermore, our demonstration that IL-4 induced the
activation of signal transducer and activator of tran-
scription 6 (STAT6) in corneal fibroblasts and that
neutralizing antibodies to IL-4 R inhibited IL-4-
induced release of the chemokine eotaxin from these
cells suggested that the IL-4R complex expressed on
their surface is functional. Both IL-4 and IL-13, which
also acts at the IL-4R complex, thus exert direct ef-
fects on ocular resident fibroblasts, suggesting that
these cells might function as important effectors in
the regulation of allergic inflammation by Th2 cytoki-
nes.
ROLE OF CONJUNCTIVAL FIBROBLASTS
IN THE FORMATION OF GIANT PAPILLAE
Giant papillae, a characteristic lesion of VKC, consist
of infiltrated inflammatory cells−such as mast cells,
eosinophils, and Th2 cells−as well as conjunctival fi-
broblasts and extracellular matrix (ECM) molecules
(Fig. 2). Immunohistochemical and biochemical stud-
ies have thus revealed increased deposition of colla-
gen types I, III, and V as well as fibronectin, tenascin,
and laminin in giant papillae.16-18 An increased abun-
dance of procollagen has also been detected in tear
fluid and the conjunctiva of patients with active
VKC.19 As in other tissues, fibroblasts are responsible
for ECM metabolism in the conjunctiva. Under nor-
mal conditions, resident fibroblasts maintain tissue
integrity by both synthesizing and degrading ECM
proteins, the latter of which is achieved by the re-
lease of matrix-degrading enzymes such as matrix
metalloproteinases (MMPs). Degradation of ECM is
further determined by the balance between the activi-
ties of MMPs and those of endogenous MMP inhibi-
tors known as tissue inhibitors of metalloproteinases
(TIMPs). Disturbance of the balance between the
synthesis and degradation of ECM underlies various
pathological conditions. If degradation exceeds syn-
thesis, the loss of ECM proteins results in breakdown
of the affected tissue. If synthesis exceeds degrada-
tion, excessive deposition of ECM proteins results in
tissue fibrosis or hyperplasia.
The hyperplasia of fibroblasts associated with the
development of giant papillae may result from a dis-
torted homeostatic balance among fibroblast recruit-
ment, proliferation, and death. We examined the ef-
fects of Th2 cytokines on these aspects of conjuncti-
val fibroblast function . IL-4 (Fig . 3) was found to
stimulate the migration of human conjunctival fibro-
blasts in a time- and concentration-dependent man-
ner. Such effects of IL-4 were also observed with der-
mal fibroblasts but not with lung fibroblasts . 20,21
Among Th2 cytokines, only IL-4 and IL-13, not IL-5,
IL-9, or IL-10, were shown to stimulate the prolifera-
tion of conjunctival fibroblasts.15 Furthermore, only
IL-4 and IL-13 (not IL-5, IL-9, or IL-10) protected con-
junctival fibroblasts from nitric oxide (NO)-induced
apoptosis, an effect that was mediated by activation of
signaling by phosphatidylinositol 3-kinase and the
protein kinase Akt . 14 These observations thus sug-
gest that the chemotactic, mitogenic, and antiapop-
totic effects of IL-4 and IL-13 on conjunctival fibro-
blasts might contribute to the hyperplasia of these
cells that underlies the formation of giant papillae in
individuals with VKC.
To clarify the contribution of Th2 cytokines to the
excessive deposition of ECM in giant papillae, we and
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Fig. 3 IL-4-induced chemotaxis of conjunctival fibroblasts in vitro. Calcein-labeled hu-
man conjunctival fibroblasts were placed in the upper wel of a Boyden blindwel chamber 
containing a filter with a pore diameter of 8 μm. The lower wel contained IL-4 at the indi-
cated concentrations (A) or at 0 (open circles) or 1.0 (closed circles) ng/ml (B). The cham-
ber was incubated at 37°C for 24 h (A) or for the indicated times (B), after which the cels 
that had migrated into the lower wel were detected by measurement of fluorescence with 
a microplate reader. Data are means ± SEM of values from three separate experiments. 
*P＜ 0.05 (Fisher’ sPLSD test) versus the coresponding value for cels incubated in the 
absence of IL-4.
A
1200
1000
800
600
400
0
0 0.1 1.0 10 100
IL-4(pg/ml)
C
he
m
ot
ac
tic
 a
ct
iv
ity
(f
lu
or
es
ce
nc
e 
in
te
ns
ity
)
1200
1000
800
600
400
200
0
0 2 6
Time(h)
24
B
C
he
m
ot
ac
tic
 a
ct
iv
ity
(f
lu
or
es
ce
nc
e 
in
te
ns
ity
)*
*
Fig. 4 IL-4- or IL-13-induced TIMP-2 release from human conjunctival fibroblasts. Cels 
were incubated for 24 h with the indicated Th2 cytokines at 10 ng/ml (A) or with the indicated 
concentrations of IL-4 (circles) or IL-13 (solid dots) (B). The concentration of TIMP-2 in cul-
ture supernatants was then determined by enzyme-linked immunosorbent assay. Data are 
expressed as nanograms of TIMP-2 released per 1×106 cels and are means ± SEM of val-
ues from four separate experiments. *P＜0.05, **P＜0.01 (Dunnet’ stest) versus the cor-
responding value for cels incubated in the absence of cytokine.
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others investigated the effects of these cytokines on
the metabolism of ECM by conjunctival fibroblasts.
IL-4 and IL-13 were each found to stimulate the syn-
thesis of collagen types I and III and fibronectin by
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Fig. 5 Role of conjunctival fibroblasts in the pathogenesis of giant papilae. 
Stimulation of conjunctival fibroblasts by the Th2 cytokines IL-4 and IL-13 
contributes to both the hyperplasia and excessive deposition of ECM that un-
derlie the development of giant papilae associated with VKC.
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these cells.15 Furthermore, IL-4 inhibited the release
by conjunctival fibroblasts of MMP-1, 22 which is
largely responsible for the degradation of collagen
type I. Conversely, IL-4 and IL-13 each promoted the
release by conjunctival fibroblasts of TIMP-1,22 which
specifically inhibits the activities of interstitial collage-
nase, gelatinase, and stromelysin . In addition, IL-4
and IL-13, but not other Th2 cytokines or the Th1 cy-
tokine interferon-γ (IFN-γ), induced TIMP-2 release
from human conjunctival fibroblasts in a
concentration-dependent manner (Fig. 4). Together,
these observations indicate that IL-4 and IL-13 act as
inhibitors of matrix degradation by conjunctival fibro-
blasts. Both the stimulatory effects of these cytokines
on ECM synthesis in , and their inhibition of ECM
degradation by , conjunctival fibroblasts may thus
contribute to the excessive deposition of ECM in gi-
ant papillae.
The interaction of leukocyte integrins with the ac-
cumulated ECM proteins in giant papillae likely pro-
vides costimulatory signals to the infiltrating inflam-
matory cells. Adhesion of leukocytes to ECM compo-
nents promotes their proliferation, prolongs their sur-
vival, or activates their expression of inflammatory cy-
tokines, growth factors, and adhesion molecules, and
the ECM also acts as a reservoir for inflammatory
mediators or growth factors.23-26 The increased depo-
sition of ECM in giant papillae is thus thought to con-
tribute to the persistence and activation of infiltrated
inflammatory cells during conjunctival allergic inflam-
mation (Fig. 5).
ROLE OF CORNEAL FIBROBLASTS IN
CORNEAL DAMAGE ASSOCIATED WITH
VKC
In contrast to the conjunctiva, primary allergic reac-
tions do not occur in the cornea because of its lack of
blood vessels and immune cells and because the bar-
rier function of the corneal epithelium prevents anti-
gens from invading the corneal stroma. Like the con-
junctiva, however, the cornea is in contact with a thin
layer of tear fluid, which, during allergic inflammation
of the conjunctiva, is rich in bioactive molecules such
as histamine, eosinophil-derived cytotoxic proteins ,
leukotrienes, proteinases, and cytokines. Exposure of
the cornea to such molecules, especially to granule
proteins released from infiltrated eosinophils , can
damage corneal epithelial cells, destroy the normal
structure of the cornea, and lead to the formation of
corneal ulcers . Corneal damage is more important
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Fig. 6 Fibroblasts in the cornea. Electron microscopy re-
veals that fibroblasts in the human cornea are loosely ar-
rayed between the lamelae formed by colagen fibers of the 
corneal stroma (A). The cytoplasmic processes of corneal fi-
broblasts are rich in intermediate filaments (B), and the long 
cytoplasmic processes of neighboring fibroblasts make con-
tact with each other to form an extensive and continuous net-
work structure paralel to the plane of the colagen lamelae 
(C). Typical gap junctions are apparent between these cyto-
plasmic processes (arows). 
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Fig. 7 Role of corneal fibroblasts in the pathogenesis of 
corneal lesions in VKC. Corneal fibroblasts are activated by 
IL-4 and IL-13 released into tear fluid as a result of conjunc-
tival alergic inflammation. The activated fibroblasts regulate 
inflammatory cel recruitment through expression of che-
mokines and adhesion molecules. The infiltration of inflam-
matory cels then leads to corneal damage.
Conjunctiva
・Giant papilla formation
・Severe allergic inflammation
Cornea
・Shield ulcer
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clinically than conjunctival changes because of the
role of the cornea in vision. Recent studies have re-
vealed that chemokines released from corneal cells
contribute to eosinophil recruitment to the cornea
and consequent corneal injury. The concentration of
eotaxin (CCL11), a potent and specific chemokine for
eosinophils, was thus found to be increased in the
tear fluid of individuals with ocular allergic diseases,
and both the number of eosinophils and the concen-
tration of eotaxin in tear fluid correlated with the ex-
tent of corneal damage.4
We and others have investigated the cellular
source of eotaxin present in tear fluid . 27,28 Human
corneal epithelial cells in culture did not release de-
tectable amounts of eotaxin into the culture medium
in response to stimulation either with tumor necrosis
factor-α (TNF-α), IL-4, or IL-13 alone or with combi-
nations thereof. In contrast, stimulation of cultured
human corneal fibroblasts (Fig . 6) with TNF-α in
combination with either IL-4 or IL-13 resulted in a
marked increase in eotaxin production that was both
time- and concentration-dependent . These results
suggested that cytokine-stimulated corneal fibro-
blasts, but not corneal epithelial cells, may represent
a major source of eotaxin in tear fluid (Fig. 7).
At sites of inflammation, the interaction of leuko-
cytes with tissue-resident cells promotes the infiltra-
tion, retention, and activation of the leukocytes. Ad-
hesion molecules such as intercellular adhesion
molecule (ICAM)-1 and vascular cell adhesion mole-
cule (VCAM)-1 expressed on the surface of these
structural cells and integrin chains expressed on the
surface of the leukocytes mediate these interactions.
In vascularized tissue , the expression of adhesion
molecules on the surface of endothelial cells facili-
tates the transmigration of leukocytes across the ves-
sel wall and into the tissue proper . In the cornea ,
however, which lacks a vasculature, the retention and
activation of leukocytes have been thought to be
regulated by corneal epithelial cells or stromal fibro-
blasts. To clarify whether corneal cells might interact
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with infiltrated eosinophils , we investigated the ex-
pression of ICAM-1 and VCAM-1 in human corneal
epithelial cells and fibroblasts. ICAM-1, which is the
ligand for leukocyte function-associated antigen
(LFA)-1 expressed on the surface of both eosinophils
and neutrophils, was found to be expressed on the
surface of both corneal epithelial cells and fibroblasts
in culture. Stimulation with the proinflammatory cy-
tokine TNF-α increased the surface expression of
ICAM-1 in both cell types, whereas the Th2 cytokines
IL-4 and IL-13 had no such effect . 29 In contrast ,
VCAM-1, which is a ligand for very late antigen
(VLA)-4 expressed on the surface of eosinophils (but
not on that of neutrophils), was not expressed by cor-
neal epithelial cells cultured in the absence or pres-
ence of cytokines. In corneal fibroblasts , however ,
stimulation with TNF-α, IL-4, or IL-13 alone induced a
small increase in the basal level of VCAM-1 expres-
sion, and exposure to the combination of TNF-α and
either IL-4 or IL-13 resulted in a marked synergistic
increase in the surface expression of this adhesion
molecule. These results suggest that the interaction
of VCAM-1 on corneal fibroblasts with VLA-4 on
eosinophils plays a key role in the pathogenesis of
corneal lesions associated with VKC (Fig. 7).
CORNEAL FIBROBLASTS AS SENTINEL
CELLS AND HETEROGENEITY OF FIBRO-
BLASTS
IFN-γ inhibits the stimulatory effects of IL-4 on immu-
noglobulin E production in vivo30 and on the develop-
ment of Th2 cell clones in vitro.31,32 The antagonism
between the Th1 cell-derived cytokine IFN-γ and the
Th 2 cell-derived cytokine IL-4 apparent in hema-
topoietic cells suggested the possibility that IFN-γ
might also inhibit the effects of Th2 cytokines on cor-
neal fibroblasts. We therefore investigated whether
IFN-γ affects Th2 cytokine-induced eotaxin synthesis
in human corneal fibroblasts.33 IFN-γ significantly in-
hibited the stimulatory effects of the proinflammatory
cytokines TNF-α, IL-1α, and IL-1β on eotaxin release
from corneal fibroblasts. Furthermore, it markedly in-
hibited the synergistic increase in eotaxin release in-
duced by the combination of TNF-α and either IL-4 or
IL-13. These results indicated that the Th1 cytokine
IFN-γ opposes the effects of Th2 cytokines on corneal
fibroblasts. Furthermore, this antagonism suggests
that fibroblasts in the corneal stroma, which lacks im-
mune cells under normal conditions, act as sentinel
cells to sense the relative abundance of Th1 and Th2
cytokines and to respond accordingly by altering
their expression of chemokines and adhesion mole-
cules.
Fibroblasts are present throughout the body, but
they do not comprise a homogeneous population of
cells. They manifest distinct structural and functional
features depending on their anatomic location within
the body and their exposure to local stimuli. 34-36 In
addition, the specific phenotypes of fibroblasts from
different sites are maintained even after prolonged
culture in vitro.37-39 The expression of chemokines in
response to exposure to lipopolysaccharide, for ex-
ample , differs between nasal and lung fibroblasts ,
demonstrating heterogeneity of fibroblasts even
within the respiratory tract . 40 Furthermore , unlike
skin and lung fibroblasts, which are of mesenchymal
origin, corneal fibroblasts are derived from the neural
ectoderm. The specific contributions of fibroblasts in
different organs to allergic inflammation, however, re-
main poorly understood.
Given that the cornea is avascular tissue that nor-
mally lacks hematopoietic and immune cells, corneal
fibroblasts (Fig. 6) might be expected to have func-
tions that differ from those of fibroblasts in other tis-
sues. To characterize the differential contributions of
fibroblasts in different tissues to the pathogenesis of
allergic diseases such as VKC, atopic dermatitis, and
asthma, we compared the effects of various cytokines
on the production of thymus- and activation-regulated
chemokine (TARC, CCL17), a potent and selective
chemoattractant for Th2 cells, by human fibroblasts
derived from the cornea, skin, and lungs.41 In corneal
and dermal fibroblasts , the combination of TNF-α
and either of the Th2 cytokines IL-4 or IL-13 induced
a marked increase in both the release of TARC and
the intracellular abundance of TARC mRNA. In con-
trast , lung fibroblasts did not release detectable
amounts of TARC in response to any of the cytokines
examined. This differential response of corneal and
dermal fibroblasts on the one hand and lung fibro-
blasts on the other suggests that these cells play dif-
ferent roles in the initiation of corresponding Th2-
dominant allergic conditions (VKC, atopic dermatitis,
and asthma , respectively ) . In addition to immune
cells such as dendritic cells and T cells , tissue-
resident epithelial cells in the nasal mucosa, lungs,
and skin produce TARC in response to cytokine
stimulation.42-44 In contrast, we have shown that cor-
neal epithelial cells do not produce TARC in response
to cytokine stimulation.45 These observations thus re-
inforce the notion that the resident cell types respon-
sible for TARC production during allergic inflamma-
tion (only fibroblasts in the cornea, both epithelial
cells and fibroblasts in the skin, and only epithelial
cells in the lungs) differ among organs and tissues.
CONCLUSION
We have shown that fibroblasts not only confer me-
chanical strength to tissue through production of the
supporting framework of the ECM but also constitute
an important source of biological mediators that con-
tribute to the initiation and amplification of allergic in-
flammation. The uncontrolled overproduction of such
mediators by fibroblasts of the eye may prevent reso-
lution of such inflammation and lead to tissue remod-
eling or destruction.8,9,46 Fibroblasts thus function as
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immune modulators during ocular allergic inflamma-
tion , modulating the activities of immune cells
through expression of adhesion molecules, chemoki-
nes, and ECM proteins. Fibroblasts are not a homo-
geneous population of cells, however, with those resi-
dent in different tissues playing distinct roles in local
allergic inflammation. Targeting of tissue-resident fi-
broblasts or fibroblast-derived factors may provide a
basis for new treatments for the giant papillae and
corneal disorders associated with VKC as well as for
other allergic diseases.
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